The rational application of antibiotics on the basis of their pharmacokinetics in infants with pneumo
Abstract
Study results of pharmacokinetics of Sizomycine and Amikacin aminoglycozyde antibiotics in infants with severe pneumonia have been shown. It was revealed that the pharmacokinetics of these drugs depends on the patients’ condition severity. A significant individual variability of the antibiotics’ pharmacokinetics was found that requires their individual dosage. The pharmacokinetic variability is due to "patient’s factors". A multiple correlation analysis demonstrated quantitative relationships between pharmacokinetic parameters and such the "patient’s factors" as body weight, leukocytes amount, red blood cells sedimentation rate, hematocrit, creatinine and urea serum concentrations, oxygen and carbon dioxide blood partial pressures. An individual prediction of pharmacokinetic parameters, e.g. a total clearance of creatinine according to the "patient’s factors" is the basis for the initial calculation of the antibiotic individual dose when it is important to determine the optimal dose quickly.
About the Author
E. V. SorokinaRussian Federation
References
1. Каганов С.Ю., Велыпищев Ю.Е. (р ед.) Пневмонии у детей. М.: М едицина; 1995.
2. Соловьев В.Н., Фирсов А.А ., Филов В.А. Фармакокинетика: (Руководство). М .: Медицина; 1980.
3. Страчунский Л.С ., Козлов С.И. Антибиотики: клиническая фармакология. Смоленск; 1994.
4. Фирсов А.А ., Панкова Г.Ф. Клиническая фармакокинетика и оптимальный режим внутривенного введения ампициллина у детей. Антибиотики 1981; 2: 114-118 .
5. Фирсов А.А., Панкова Г.Ф. Создание заданной концентрации тобрамицина и сизомицина в крови детей раннего возраста путем внутривенной инфузии антибиотиков в расчетном режиме. Там же 1982; 11: 30-35.
6. Яковлев С.В. Клиническая химиотерапия бактериальных инфекций. М.: Ньюдиамед-АО; 1997.
7. Chuck S.K ., Raber S.R ., Rodvold К .А., Areff D. National survey of extended-interval am inoglycoside dosing. Clin. Infect. Dis. 2000; 30 (3): 433-439.
8. Fanos V., Cataldi L. A ntibacterial-induced nephrotoxicity in the new born. D rug Saf. 1999; 20 (3): 245-267.
9. Garraffo R. Optimal adaptive control of pharmacodynamic effects with am inoglycoside antibiotics: a required approach for the future. Int. J. Biom ed. Comput. 1994; 36 (1-2) : 43-57.
10. Kollef M .N . Ventilato r-asso ciated pneumonia: the im portance of initialem pirical antibiotic selection. Infect. M ed. 2000; 17 (4): 278-283.
11. Langlass T.M., Mickle T.R. Standard gentamicin dosage regimen in neonates. Am . J. Hlth Syst. Pharm . 1999; 56 (5): 440-443.
12. Long S.S., Pickering L.K., Prober C.G., eds. Principles and practice of pediatric infectious diseases. New York; 1997.
13. Poutledge P.A. Pharmacokinetics in children. J. Antim icrob. Chem other. 1994; 34 (suppl. A): 19-24.
14. Tod М., Padoin C., Petitjean O. Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clin. Pharmacokin et. 2000; 38 (3): 205-223.
15. Toyonaga Y. Pharmacokinetics of antibiotics in children. Acta Paediatr. Jpn. 1997; 39 (1): 114-123.
16. Vogel F. Sequential therapy in the hospital management of lower respiratory infections. Amer. J. Med. 1995; 99 (6b): 9-14.
17. Yurdakok M. Antibiotic use in neonatal sepsis. Turk. J. Pediatr. 1998; 40 (1): 17-33.
Review
For citations:
Sorokina E.V. The rational application of antibiotics on the basis of their pharmacokinetics in infants with pneumo. PULMONOLOGIYA. 2002;(1):23-28. (In Russ.)